CN113577156A - Moxa stick for improving leucocyte and organism immunity and using method thereof - Google Patents

Moxa stick for improving leucocyte and organism immunity and using method thereof Download PDF

Info

Publication number
CN113577156A
CN113577156A CN202110581316.4A CN202110581316A CN113577156A CN 113577156 A CN113577156 A CN 113577156A CN 202110581316 A CN202110581316 A CN 202110581316A CN 113577156 A CN113577156 A CN 113577156A
Authority
CN
China
Prior art keywords
parts
moxa
mint
codonopsis pilosula
lucid ganoderma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110581316.4A
Other languages
Chinese (zh)
Inventor
程燕红
冯调梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanxi Chengshi Huitong Technology Co Ltd
Original Assignee
Shanxi Chengshi Huitong Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi Chengshi Huitong Technology Co Ltd filed Critical Shanxi Chengshi Huitong Technology Co Ltd
Priority to CN202110581316.4A priority Critical patent/CN113577156A/en
Publication of CN113577156A publication Critical patent/CN113577156A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A61H39/06Devices for heating or cooling such points within cell-life limits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/074Ganoderma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/344Codonopsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a moxa stick for improving leukocyte and organism immunity, which comprises the following components, by weight, 2-10 parts of mint, 24-32 parts of astragalus membranaceus, 2-10 parts of codonopsis pilosula, 1-5 parts of angelica sinensis, 2-10 parts of dried orange peel, 2-10 parts of cimicifuga foetida, 5-13 parts of bighead atractylodes rhizome, 5-13 parts of lucid ganoderma, 15-25 parts of sanguisorba officinalis and 200 parts of moxa 160-. The invention belongs to the technical field of moxibustion, and aims to provide a solution to administration route, wherein a traditional Chinese medicine oral administration method is changed into an external treatment method, the administration route of a traditional patient with oral administration difficulty is overcome, the technical effect of good curative effect of a cold-dampness patient corresponding to permeation and absorption is realized, and inheritance and development creation of the traditional moxibustion are realized.

Description

Moxa stick for improving leucocyte and organism immunity and using method thereof
Technical Field
The invention belongs to the technical field of moxibustion, and particularly relates to a moxa stick for improving leucocyte and organism immunity and a using method thereof.
Background
Moxibustion, a moxibustion method in traditional Chinese medicine therapy, is a treatment method for preventing and treating diseases by stimulating acupuncture points or specific parts on the body surface by moxa heat generated by moxa materials made of folium artemisiae argyi and regulating physiological and biochemical functions of human body disorder by exciting the activity of meridian qi. The leucocyte increasing in western medicine is usually medicines such as colony stimulating factors, which can quickly increase the leucocyte, but the leucocyte increasing is quickly injected into the western medicine, so that the leucocyte is promoted to proliferate and mature and is adjusted to peripheral blood, so that a plurality of times of chemotherapy is clinically performed, the colony stimulating factors are used, the hemogram is difficult to improve, and after the leucocyte increasing needle is used in the western medicine, bone pain is caused, and the leucocyte in the bone is adjusted to the periphery, so that bone headache is caused. The traditional Chinese medicine does not have the defects, and although the traditional Chinese medicine is slow, the white blood cell rising is quick and continuous, and the white blood cell decline is avoided due to the disuse of the moxibustion. In traditional Chinese medicine, Zusanli is the acupoint of the stomach channel, Qihai and Guanyuan are the places of original qi, which are the places of Dantian of Daojia and can greatly tonify original qi, Zusanli is the acupoint of spleen and stomach, and the acupoint can lift white through regulating spleen and stomach, tonifying spleen and kidney and warming yang of moxibustion. In summary, there are two ways to promote the white blood flow, one is the kidney and the other is the spleen and stomach. The spleen and stomach are the sources of qi and blood, so the two are combined to play a role. The traditional treatment means can accelerate the technical effect of internal and external simultaneous treatment by matching with the taking of medicines, but the medicine taking of patients with oral difficulty is difficult, and the treatment effect is very little.
Disclosure of Invention
In view of the above situation, in order to overcome the defects of the prior art, the invention aims to provide a solution to the administration route, which is an external treatment method instead of oral administration of traditional Chinese medicines, overcomes the administration route of traditional patients with oral difficulties, realizes the technical effect of good curative effect on cold-dampness patients through absorption, and realizes inheritance and development creation on traditional moxibustion.
The technical scheme adopted by the invention is as follows: a moxa roll for improving leukocyte and organism immunity comprises the following components in parts by weight: 2-10 parts of mint, 24-32 parts of astragalus membranaceus, 2-10 parts of codonopsis pilosula, 1-5 parts of angelica sinensis, 2-10 parts of pericarpium citri reticulatae, 2-10 parts of rhizoma cimicifugae, 5-13 parts of bighead atractylodes rhizome, 5-13 parts of lucid ganoderma, 15-25 parts of sanguisorba officinalis and 200 parts of moxa 160-containing materials.
Further, the moxa roll for improving the immunity of white blood cells and organisms comprises the following components in parts by weight: 4-8 parts of mint, 26-30 parts of astragalus membranaceus, 4-8 parts of codonopsis pilosula, 2-4 parts of angelica sinensis, 4-8 parts of pericarpium citri reticulatae, 4-8 parts of rhizoma cimicifugae, 8-10 parts of bighead atractylodes rhizome, 8-10 parts of lucid ganoderma, 18-22 parts of sanguisorba officinalis and 190 parts of moxa 170-.
Further, the moxa stick for improving the immunity of the white blood cells and the organism comprises the following components in parts by weight: 6 parts of mint, 28 parts of astragalus membranaceus, 6 parts of codonopsis pilosula, 3 parts of angelica sinensis, 6 parts of pericarpium citri reticulatae, 6 parts of cimicifugae foetidae, 9 parts of bighead atractylodes rhizome, 9 parts of lucid ganoderma, 20 parts of garden burnet and 180 parts of moxa.
A use method of moxa roll for improving leukocyte and organism immunity comprises the following steps:
the method comprises the following steps: weighing the components of the raw materials to obtain weighed raw materials;
step two: taking out the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet from the weighed raw materials, and simultaneously taking out the moxa, wherein the sum of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the lucid ganoderma and the garden burnet accounts for 30% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the lucid ganoderma and the moxa, and the moxa accounts for 70% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma, the garden burnet and the moxa;
step three: stirring and rolling the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet which are taken out in the step two by moxa wool to prepare moxa sticks;
step four: the Shenque acupoint is used as the main part, and is matched with other acupoints for administration, the supported moxa stick is hot-compressed on the skin, and pores of the skin are opened by hot compression to achieve ventilation and administration.
After the technical scheme is adopted, the invention has the following beneficial effects: provides a solution to the administration route, changes the oral administration of traditional Chinese medicines into an external treatment method, overcomes the administration route of the traditional patients with difficult oral administration, realizes the technical effect of good curative effect corresponding to cold-dampness patients through absorption, and realizes inheritance and development creation to the traditional moxibustion.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments; all other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1A moxa roll for improving the immunity of white blood cells and organisms comprises the following components in parts by weight: 2 parts of mint, 24 parts of astragalus membranaceus, 2 parts of codonopsis pilosula, 1 part of angelica sinensis, 2 parts of pericarpium citri reticulatae, 2 parts of cimicifugae foetidae, 5 parts of bighead atractylodes rhizome, 5 parts of lucid ganoderma, 15 parts of garden burnet and 160 parts of moxa.
A use method of moxa roll for improving leukocyte and organism immunity comprises the following steps:
the method comprises the following steps: weighing the components of the raw materials to obtain weighed raw materials;
step two: taking out the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet from the weighed raw materials, and simultaneously taking out the moxa, wherein the sum of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the lucid ganoderma and the garden burnet accounts for 30% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the lucid ganoderma and the moxa, and the moxa accounts for 70% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma, the garden burnet and the moxa;
step three: stirring and rolling the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet which are taken out in the step two by moxa wool to prepare moxa sticks;
step four: the Shenque acupoint is used as the main part, and is matched with other acupoints for administration, the supported moxa stick is hot-compressed on the skin, and pores of the skin are opened by hot compression to achieve ventilation and administration.
Example 2: a moxa roll for improving leukocyte and organism immunity comprises the following components in parts by weight: 6 parts of mint, 28 parts of astragalus membranaceus, 6 parts of codonopsis pilosula, 3 parts of angelica sinensis, 6 parts of pericarpium citri reticulatae, 6 parts of cimicifugae foetidae, 9 parts of bighead atractylodes rhizome, 9 parts of lucid ganoderma, 20 parts of garden burnet and 180 parts of moxa.
A use method of moxa roll for improving leukocyte and organism immunity comprises the following steps:
the method comprises the following steps: weighing the components of the raw materials to obtain weighed raw materials;
step two: taking out the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet from the weighed raw materials, and simultaneously taking out the moxa, wherein the sum of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the lucid ganoderma and the garden burnet accounts for 30% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the lucid ganoderma and the moxa, and the moxa accounts for 70% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma, the garden burnet and the moxa;
step three: stirring and rolling the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet which are taken out in the step two by moxa wool to prepare moxa sticks;
step four: the Shenque acupoint is used as the main part, and is matched with other acupoints for administration, the supported moxa stick is hot-compressed on the skin, and pores of the skin are opened by hot compression to achieve ventilation and administration.
Example 3: a moxa roll for improving leukocyte and organism immunity comprises the following components in parts by weight: 10 parts of mint, 32 parts of astragalus membranaceus, 10 parts of codonopsis pilosula, 5 parts of angelica sinensis, 10 parts of pericarpium citri reticulatae, 10 parts of rhizoma cimicifugae, 13 parts of bighead atractylodes rhizome, 13 parts of ganoderma lucidum, 25 parts of garden burnet and 200 parts of moxa.
A use method of moxa roll for improving leukocyte and organism immunity comprises the following steps:
the method comprises the following steps: weighing the components of the raw materials to obtain weighed raw materials;
step two: taking out the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet from the weighed raw materials, and simultaneously taking out the moxa, wherein the sum of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the lucid ganoderma and the garden burnet accounts for 30% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the lucid ganoderma and the moxa, and the moxa accounts for 70% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma, the garden burnet and the moxa;
step three: stirring and rolling the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet which are taken out in the step two by moxa wool to prepare moxa sticks;
step four: the Shenque acupoint is used as the main part, and is matched with other acupoints for administration, the supported moxa stick is hot-compressed on the skin, and pores of the skin are opened by hot compression to achieve ventilation and administration.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
The present invention and its embodiments have been described above, but the description is not limitative, and the actual structure is not limited thereto. In summary, those skilled in the art should appreciate that they can readily use the disclosed conception and specific embodiments as a basis for designing or modifying other structures for carrying out the same purposes of the present invention without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (4)

1. A moxa roll for improving the immunity of white blood cells and organisms is characterized by comprising the following components in parts by weight: 2-10 parts of mint, 24-32 parts of astragalus membranaceus, 2-10 parts of codonopsis pilosula, 1-5 parts of angelica sinensis, 2-10 parts of pericarpium citri reticulatae, 2-10 parts of rhizoma cimicifugae, 5-13 parts of bighead atractylodes rhizome, 5-13 parts of lucid ganoderma, 15-25 parts of sanguisorba officinalis and 200 parts of moxa 160-containing materials.
2. The moxa roll for improving the immunity of white blood cells and organisms according to claim 1, which is characterized by comprising the following components in parts by weight: 4-8 parts of mint, 26-30 parts of astragalus membranaceus, 4-8 parts of codonopsis pilosula, 2-4 parts of angelica sinensis, 4-8 parts of pericarpium citri reticulatae, 4-8 parts of rhizoma cimicifugae, 8-10 parts of bighead atractylodes rhizome, 8-10 parts of lucid ganoderma, 18-22 parts of sanguisorba officinalis and 190 parts of moxa 170-.
3. The moxa roll for improving the immunity of white blood cells and organisms according to claim 1, which is characterized by comprising the following components in parts by weight: 6 parts of mint, 28 parts of astragalus membranaceus, 6 parts of codonopsis pilosula, 3 parts of angelica sinensis, 6 parts of pericarpium citri reticulatae, 6 parts of cimicifugae foetidae, 9 parts of bighead atractylodes rhizome, 9 parts of lucid ganoderma, 20 parts of garden burnet and 180 parts of moxa.
4. A use method of a moxa roll for improving leukocyte and organism immunity is characterized by comprising the following steps:
the method comprises the following steps: weighing the components of the raw materials to obtain weighed raw materials;
step two: taking out the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet from the weighed raw materials, and simultaneously taking out the moxa, wherein the sum of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the lucid ganoderma and the garden burnet accounts for 30% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the lucid ganoderma and the moxa, and the moxa accounts for 70% of the total amount of the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma, the garden burnet and the moxa;
step three: stirring and rolling the mint, the astragalus, the codonopsis pilosula, the angelica, the dried orange peel, the cimicifuga foetida, the bighead atractylodes rhizome, the lucid ganoderma and the garden burnet which are taken out in the step two by moxa wool to prepare moxa sticks;
step four: the Shenque acupoint is used as the main part, and is matched with other acupoints for administration, the supported moxa stick is hot-compressed on the skin, and pores of the skin are opened by hot compression to achieve ventilation and administration.
CN202110581316.4A 2021-05-27 2021-05-27 Moxa stick for improving leucocyte and organism immunity and using method thereof Pending CN113577156A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110581316.4A CN113577156A (en) 2021-05-27 2021-05-27 Moxa stick for improving leucocyte and organism immunity and using method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110581316.4A CN113577156A (en) 2021-05-27 2021-05-27 Moxa stick for improving leucocyte and organism immunity and using method thereof

Publications (1)

Publication Number Publication Date
CN113577156A true CN113577156A (en) 2021-11-02

Family

ID=78243296

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110581316.4A Pending CN113577156A (en) 2021-05-27 2021-05-27 Moxa stick for improving leucocyte and organism immunity and using method thereof

Country Status (1)

Country Link
CN (1) CN113577156A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117959374A (en) * 2024-03-26 2024-05-03 广州中医药大学(广州中医药研究院) Preparation method and application of Chinese medicine health-care roasted smoked drink composition with both medicinal and edible properties

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107823409A (en) * 2017-11-24 2018-03-23 上海坤慧生物科技有限公司 A kind of medicine of traditional Chinese medicine moxibustion
CN108743897A (en) * 2018-08-07 2018-11-06 华夏博力健康产业股份有限公司 The method for preparing human body yin-yang balancing moxa

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107823409A (en) * 2017-11-24 2018-03-23 上海坤慧生物科技有限公司 A kind of medicine of traditional Chinese medicine moxibustion
CN108743897A (en) * 2018-08-07 2018-11-06 华夏博力健康产业股份有限公司 The method for preparing human body yin-yang balancing moxa

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
聂成梅: "穴位敷灸治疗化疗后白细胞减少的护理观察", 《当代护士》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117959374A (en) * 2024-03-26 2024-05-03 广州中医药大学(广州中医药研究院) Preparation method and application of Chinese medicine health-care roasted smoked drink composition with both medicinal and edible properties
CN117959374B (en) * 2024-03-26 2024-07-19 广州中医药大学(广州中医药研究院) Preparation method and application of medicinal and edible traditional Chinese medicine health care moxibustion fumigation composition

Similar Documents

Publication Publication Date Title
CN102068661A (en) Chinese medical formula for treating female blood stasis, blood deficiency and deep thready pulse dysmenorrhea
CN113577156A (en) Moxa stick for improving leucocyte and organism immunity and using method thereof
CN1054895A (en) The SHENGONG YUANQI BAG drug core preparation technology
CN105920243A (en) Decoction benefiting kidney tonifying, blood circulation promoting and liver soothing
CN109453460A (en) Remedies hot compress moxibustion matrix, Chinese medicine composition and preparation method containing it
CN107496585A (en) It is a kind of that there is warming kidney and enhancing body, the lavipeditum pack of bowl spares function of invigorating spleen
CN1236638A (en) Medical wine for treating rheumatism
CN1081916A (en) Medicinal and magnetic bag
CN211356749U (en) Magnetic energy moxibustion instrument
CN1060073C (en) Externally used medicine bag for curing chronic pelvic infection, endometriosis, chronic cervicitis and menalgia and its making process
CN2902239Y (en) Eye-shield for treating eyes with traditional Chinese medicine
CN101721503A (en) Traditional Chinese medicine preparation for treating sterility and infertility of men and women
CN104644871A (en) High-temperature medicated bath antisenescence therapeutic method
CN1074291C (en) Medicinal ox horn
CN110302270A (en) Acupoint plaster for treating diabetic neuropathy and preparation method thereof
CN100371038C (en) Health caring hair cover with hair-restorer
CN101843810A (en) Medicinal liquor for treating bi syndromes and preparation method thereof
CN214511887U (en) Multifunctional thumb-tack needle
CN1060070C (en) External application medicinal bag for curing acute and chronic cholecystitis and its producing method
CN2170771Y (en) Vitiligo media lubricant introducing apparatus
CN101249250A (en) Medicinal liquor preparations for curing stagnation and blood stasis chest stuffiness and pain
CN1127650A (en) External use medicine bag for treatment of woman dysmenorrhea and its making method
CN107376107A (en) Hyperthermia bed and its application method for anti-aging
CN207322770U (en) A kind of Far infrared medical magnetic health care massage scarf for prophylactic treatment hypertension
CN2338029Y (en) Herb medicine introducing shoe pad for preventing or treating apoplexy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20211102